Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Osteoporosis 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Leukemia 2Bone Diseases, Metabolic 2Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Giant Cell Tumor of Bone 1Dwarfism, Pituitary 1Disease Progression 1Carcinoma, Non-Small-Cell Lung 1Arthralgia 1

Interventions

Denosumab 3Vitamin D 1Dasatinib 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Giant Cell Tumor of Bone × Calcium × Clear all
NCT00396279 2022-11-08

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Amgen

Phase 2 Completed
37 enrolled 13 charts

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡